Henry Schein Now Exclusive Distributor of Curodont Remineralization Solution to DSOs

Curodont™ Repair Fluoride Plus, a proprietary solution that addresses early-stage tooth decay, will be exclusively distributed by Henry Schein, Inc, it was announced this week.

Henry Schein announced Tuesday that it has reached an agreement with the Swiss company vVARDIS to serve as the exclusive distributor of their drill-free Curodont Repair Fluoride Plus product to larger dental service organizations (DSOs) in the U.S.

Developed by vVARDIS, the creative product is a proprietary solution that addresses early-stage tooth decay by aiding in the preventive treatment of cavity progression, with an innovative simple, quick, and drill-free application. It is widely recognized that poor oral health can impact overall health, and untreated decay can become life-threatening. Nearly 80% of all patients have signs of early decay and studies indicate the majority will leave the dental office without treatment, which can lead to more serious disease. Curodont Repair Fluoride Plus can provide dental practices the ability to address this untapped opportunity, expanding patient care with a non-invasive approach, Henry Schein states.

“We believe that Curodont advances clinical care by treating early decay before it worsens,” Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, says in a press release.“With this treatment, the dental team can treat early-stage caries non-invasively and on the same day instead of sending patients home untreated. Henry Schein is pleased to bring products to market that improve clinical outcomes, including Curodont Repair Fluoride Plus, while helping practices operate more efficiently and effectively by advancing oral health and overall health for the ultimate benefit of the patient.”

The new partnership between Henry Schein and vVARDIS builds on other innovations that support early treatment of oral disease. In late 2022, Henry Schein One introduced Dentrix® Detect AI, powered and manufactured by VideaHealth. Dentrix Detect AI is an AI-enabled x-ray analysis tool that provides real-time clinical decision support and can detect incipient carious lesions more accurately than the naked eye, expanding the patient population that could benefit from the use of products like Curodont Repair Fluoride Plus. Dental professionals who use the Dentrix AI tool and the innovative fluoride product together may help to more effectively treat early carious lesions before greater disease progression occurs, the companies state.

Related reading: VideaHealth and vVARDIS Form Partnership Around Preventive Dental Care

Currently, Henry Schein is the market leader in selling Curodont™ Repair Fluoride Plus to general practitioners and DSOs. With this agreement, the distributor will have the exclusive rights to distribute the product to larger DSOs, a market segment that is driving significant growth. Henry Schein will continue to distribute Curodont products to other segments of the market and in other markets outside of North America, as product registrations are obtained, the company says. The terms of the agreement were not disclosed.

“We are excited to strengthen our partnership with Henry Schein, a recognized leader in driving technological innovation in dentistry,” adds Drs. Haley and Goly Abivardi, DMDs, visionary founders and co-CEOs of vVARDIS. “Henry Schein’s global reach makes for an ideal partner as we share a common goal: advancing oral health by providing access to innovative, non-invasive solutions. Through this partnership, almost every patient can now benefit from Curodont. As both dentists and entrepreneurs, we are thrilled to finally have and offer a novel approach to treating early decay. Dental professionals have been waiting for decades for a drill-free treatment that addresses the sub-clinical signs of caries immediately, without sending patients home untreated and compromising their overall health. With its seamless integration into existing workflows, we believe that Curodont has the potential to rapidly become the new standard of care for the treatment of early caries, broadening the scope of services offered and empowering dentists and hygienists to lead the way in the management of early caries, ultimately enhancing patient care.”